Group 1 - The stock price of Dongcheng Pharmaceutical is reported at 16.49 yuan, down 1.02 yuan from the previous trading day, with a decline of 5.83% [1] - The opening price was 17.55 yuan, with a highest price of 17.60 yuan and a lowest price of 16.43 yuan. The trading volume reached 243,800 hands, with a transaction amount of 415 million yuan [1] - Dongcheng Pharmaceutical's main business includes the research, production, and sales of heparin raw materials and preparations, as well as nuclear medicine products. The company operates in sectors such as chemical pharmaceuticals, Shandong sector, Helicobacter pylori concept, specialized and innovative, and heparin concept [1] Group 2 - On August 26, Dongcheng Pharmaceutical announced that Vice General Manager Wu Xiaoming applied for resignation due to work adjustment reasons. After resignation, he will still serve as the executive director and general manager of the holding subsidiary Yantai Lannacheng Biotechnology Co., Ltd. The company stated that Wu Xiaoming's resignation will not affect the company's related work and production operations [1] - On August 27, the net outflow of main funds from Dongcheng Pharmaceutical was 51.0466 million yuan, accounting for 0.42% of the circulating market value. Over the past five days, the cumulative net outflow of main funds reached 59.0739 million yuan, accounting for 0.48% of the circulating market value [1]